What is Traditional Chinese Medicine?

Traditional Chinese medicine (TCM) is a comprehensive medical system developed over approximately 2,500 years, with foundational texts including the Huangdi Neijing (Yellow Emperor's Classic of Internal Medicine, 3rd-1st century BCE) and Ben Cao Gang Mu (Compendium of Materia Medica, Li Shizhen, 1578). TCM encompasses: herbal medicine (the most widely used component — thousands of plant, mineral and animal preparations); acupuncture; moxibustion (burning moxa herb near acupoints); cupping therapy; tui na (massage); qi gong (movement + breath + intention); and dietary therapy. It is based on concepts of qi (life force), yin-yang balance and five-element theory — frameworks without direct biomedical equivalents but which contain sophisticated empirical observations about health and disease accumulated over millennia.

What is the strongest evidence from TCM?

By far: artemisinin for malaria. Tu Youyou's team, using ancient TCM texts as a research database, identified Artemisia annua as a candidate, extracted and purified artemisinin, conducted clinical trials, and produced what became the WHO standard malaria treatment — saving millions of lives. This Nobel Prize-winning discovery proves that traditional medicine knowledge can generate transformative conventional medicine discoveries when approached with scientific rigor. The second strongest evidence: acupuncture (see acupuncture hub) — NICE-approved for chronic pain and migraine. Third: Tai Chi — Cochrane evidence for falls prevention and balance in elderly. Much of TCM herbal medicine beyond these examples has limited or variable evidence.

What is aristolochic acid and why does it matter?

Aristolochic acids are potent nephrotoxins and IARC Group 1 carcinogens naturally present in Aristolochia plant species, which were used in TCM preparations (Guang Fang Ji for joint pain; Xi Xin for respiratory conditions; Mu Tong for urinary conditions). Exposure causes aristolochic acid nephropathy (AAN) — rapidly progressive renal fibrosis leading to end-stage renal failure, followed by urothelial carcinoma of the renal pelvis and ureter. The Belgium epidemic (1991-1998, 105 cases from a weight-loss clinic substituting Aristolochia fangchi for a safe herb) is the clearest documented case. Aristolochia species are now banned in EU, USA, UK and most regulated markets — but remain available in unregulated markets globally. This is TCM's most serious documented safety failure.

Is TCM compatible with conventional medicine?

Most components can be used alongside conventional medicine with appropriate precautions — but some herb-drug interactions are significant. Safe concurrent use (with disclosure): acupuncture; tai chi; qi gong; most single-herb TCM preparations (with the exceptions noted). Important interactions: some Chinese herbs are CYP3A4 inducers or inhibitors — similar risks to St John's Wort. Specific concerns: Dan Shen (Salvia miltiorrhiza) — interacts with warfarin; Ma Huang (Ephedra) — cardiovascular risk, banned as supplement in USA; Gan Cao (licorice root) — potassium depletion, hypertension, interacts with diuretics. ALWAYS disclose TCM herb use to conventional prescribers.

This question requires careful, evidence-based answering. No TCM treatment has been demonstrated to cure cancer in rigorous clinical trials. Artemisinin derivatives are being studied as potential anti-cancer agents with some early-phase evidence. Some Chinese herbal medicines show anti-cancer activity in vitro and animal models — but in vitro evidence frequently fails to translate to clinical efficacy. TCM is used as complementary (alongside conventional cancer treatment) in China and increasingly elsewhere — evidence suggests some benefit for chemotherapy-related fatigue, nausea and quality of life. The critical safety warning: replacing evidence-based cancer treatment with TCM is harmful and potentially fatal. Complementary use alongside evidence-based oncology may have benefits; replacement does not.

How does GMJ News cover TCM?

GMJ News covers the artemisinin-Nobel Prize discovery, WHO ICD-11 Chapter 26 recognition, TCM TCIM strategy integration, acupuncture evidence (separate hub), Tai Chi falls prevention evidence, aristolochic acid nephropathy (the key safety crisis), herbal quality control challenges, Chinese pharmacopoeia standards, cupping therapy evidence, and the qi/meridian framework (philosophical, not demonstrated anatomically). GMJ position: TCM contains genuinely valuable knowledge (artemisinin, acupuncture, tai chi) that rewards scientific investigation, alongside practices with inadequate evidence and serious safety risks (aristolochic acid) — evaluation must be condition-by-condition and evidence-by-evidence.

Home › Topics › Traditional Chinese Medicine

Traditional Chinese Medicine

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

Summary Statistics Glossary GMJ news FAQ Documents Organizations Research

Traditional Chinese medicine (TCM) — the systematic codification of over 2,500 years of empirical medical knowledge, now formally recognised in WHO ICD-11 Chapter 26 and at the centre of the WHO Global Traditional Medicine Strategy 2025–2034 — produced the most important discovery in malaria treatment in 50 years: artemisinin from the qinghao plant (Artemisia annua), discovered by Tu Youyou using TCM manuscripts, awarded the 2015 Nobel Prize in Physiology or Medicine and now the WHO-recommended standard for uncomplicated malaria globally — demonstrating that systematic scientific investigation of traditional knowledge can yield transformative therapeutic discoveries (WHO). Yet TCM also carries genuine risks that require scientific transparency: aristolochic acid (found in Aristolochia species used in TCM) causes severe progressive nephropathy, end-stage renal failure and urothelial carcinoma — banned in the EU and USA but still circulating in unregulated markets.

Key messages

Artemisinin — Nobel Prize 2015 — TCM to frontline medicine

Tu Youyou screened ancient TCM texts during the Cultural Revolution for malaria treatments, identifying Artemisia annua (qinghao) as a candidate. Her team extracted artemisinin (青蒿素) in 1971. Today, artemisinin-based combination therapies (ACTs) are the WHO-recommended first-line treatment for uncomplicated Plasmodium falciparum malaria globally — saving millions of lives. Tu Youyou was awarded the 2015 Nobel Prize in Physiology or Medicine. This is the definitive proof that systematic scientific investigation of traditional medicine knowledge can yield world-changing discoveries.

WHO ICD-11 Chapter 26 — formal international recognition

The WHO International Classification of Diseases 11th Revision (ICD-11, 2019) includes Chapter 26 specifically for traditional medicine conditions using East Asian medicine terminology — marking the first formal international recognition of TCM diagnostic categories in the global disease classification system. This reflects WHO's integration-with-evidence approach.

Aristolochic acid — TCM's most serious safety crisis

Aristolochic acid (AA) — a naturally occurring nephrotoxin found in Aristolochia species historically used in TCM (Guang Fang Ji, Xi Xin) — causes aristolochic acid nephropathy (AAN): rapidly progressive renal fibrosis, end-stage renal failure and urothelial carcinoma. Thousands of cases documented in Belgium (1990s — weight loss herbal clinic); China; Taiwan. AA is a potent IARC Group 1 carcinogen. Aristolochia species are banned in EU, USA, UK, Australia. Still circulating in unregulated markets. This is TCM's most serious documented safety crisis.

Quality control — the central challenge

The TCM herbal market suffers from: species substitution (wrong plant species, same name); adulteration (pharmaceutical drugs added — steroids, sildenafil, heavy metals); varying active constituent concentrations; pesticide contamination; microbial contamination. Standardisation is improving in China (2020 Chinese Pharmacopoeia, 10th edition) but remains inconsistent globally, particularly in unregulated export markets.

Acupuncture — the best-evidenced TCM modality

Acupuncture (see standalone acupuncture hub) is the most scientifically evaluated TCM modality — NICE-approved for chronic pain and migraine prevention. It is separable from the broader TCM framework and has been evaluated on its own clinical merits. The evidence for acupuncture does not require accepting the qi/meridian framework.

Integrative medicine — China's model

China has built an integrated health system where TCM hospitals function alongside conventional hospitals, and patients can receive both simultaneously. The 2019 Chinese government "Plan for Promoting the Inheritance and Innovation of TCM" set national goals for TCM research and integration. The WHO-recommended approach: evidence-informed integration, not uncritical adoption — evaluate each TCM modality by the evidence for its specific claims.

Key statistics

Nobel 2015

Tu Youyou — artemisinin from Artemisia annua (TCM) — Nobel Prize in Physiology or Medicine

Nobel Committee 2015

ICD-11 Ch.26

WHO formally recognised TCM diagnostic categories in ICD-11 (2019)

WHO ICD-11 2019

Aristolochic acid

Group 1 carcinogen; causes end-stage renal disease and urothelial carcinoma

IARC/WHO

1B+ users

traditional Chinese medicine used by over 1 billion people globally

WHO/TCM

2,500yr

documented history of TCM (Huangdi Neijing — Yellow Emperor's Classic)

History

2020

year of 10th edition Chinese Pharmacopoeia — improved quality standards

China NMPA

TCM modalities — evidence grade and integration status

Source: WHO/Cochrane. Acupuncture strongest; herbal medicine variable; qi gong promising; tai chi evidence-based for elderly.

Glossary of key terms

Artemisinin and ACTs
WHO/NobelArtemisinin (from Artemisia annua, qinghao plant) is an endoperoxide sesquiterpene lactone — it kills Plasmodium falciparum parasites through a free-radical mechanism activated in the parasite's haem-rich environment. WHO recommends artemisinin-based combination therapies (ACTs) as first-line for all uncomplicated P. falciparum malaria: artemether-lumefantrine (AL); artesunate-amodiaquine; dihydroartemisinin-piperaquine. Artesunate (IV) is first-line for severe malaria. Tu Youyou's discovery of artemisinin exemplifies how traditional medicine knowledge, combined with rigorous scientific methodology, can yield transformative clinical discoveries.

Qi (气) and meridians (经络)
TCM PhilosophyQi: the fundamental concept in TCM — life energy or vital force that flows throughout the body. Health is harmonious qi flow; disease represents qi disruption, stagnation or imbalance. Meridians (jingluo): 12 primary + 8 extraordinary channels through which qi flows, connecting acupoints to organs. Neither qi nor meridians have demonstrable anatomical correlates on modern imaging or histological study. The TCM framework is a sophisticated classification system developed through centuries of empirical observation — but it is a historical model, not a demonstrated physical reality. Evidence-based TCM practitioners use traditional point locations while explaining mechanisms through modern neuroscience.

Aristolochic acid nephropathy (AAN)
WHO/NephrologyFirst recognised as an epidemic among weight-loss clinic users in Belgium (1991-1998): 105 women who took a slimming preparation containing Aristolochia fangchi developed rapidly progressive renal fibrosis, end-stage renal disease and urothelial carcinoma. Subsequent global cases: Taiwan (endemic exposure via Chinese herbal medicines); China; UK. Mechanism: aristolochic acids I and II form DNA adducts causing characteristic A-to-T transversion mutations, visible as a specific mutational signature in urothelial cancers — enabling forensic confirmation of aristolochic acid causation. Aristolochia species are banned in EU, USA, UK, Australia, Canada. Remaining risk: persistence in unregulated markets and traditional herbal dispensaries.

Tai Chi — the evidence-based TCM practice
Cochrane/WHOTai Chi (太極拳) — slow, flowing movement sequences with mindful attention — has a substantially different evidence base from TCM herbal medicine. Cochrane 2017 (Wayne): Tai Chi reduces falls by approximately 20% in older adults; improves balance and fear of falling; reduces blood pressure modestly; improves depression and anxiety scores. Systematic reviews also support Tai Chi for knee OA, fibromyalgia, COPD and Parkinson's disease balance. WHO TCIM strategy endorses Tai Chi. The evidence is independent of acceptance of any TCM philosophical framework — Tai Chi is a form of mind-body exercise with measurable physiological effects.

Chinese pharmacopoeia and quality standards
China NMPAThe Chinese Pharmacopoeia (中国药典), published by China's National Medical Products Administration (NMPA), sets official quality standards for TCM herbal medicines. The 2020 10th edition (4 volumes) includes: standards for individual herbs (morphological identification, chromatographic fingerprinting, active constituent quantification, pesticide residue limits, heavy metal limits, microbial contamination limits). China has significantly strengthened pharmacopoeia standards since 2010. However, enforcement varies, export products are inconsistently standardised, and counterfeit products remain a significant market problem globally.

Cupping therapy — evidence and mechanism
WHO/ResearchCupping therapy: glass or plastic cups applied to skin, with suction (by heat or mechanical pump) — causing local tissue ischaemia, vasodilation and the characteristic circular bruising. Used extensively in TCM, also in Greek, Islamic (Hijama) and other traditional systems. Evidence: limited and inconsistent RCTs for neck and shoulder pain, acne, herpes zoster. No reliable Cochrane reviews. Mechanism proposed: increased local blood flow; fascial release; counter-irritant effect (similar to DNIC in acupuncture). Risk: burns (fire cupping without care); haematoma; burns from hot cup glass — minor but preventable.